Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial-Reference-Cited by-同舟云学术

Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial

Published:2020-05-01 Issue:8 Volume:115 Page:1217-1225
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Yim Hyung Joon,Kim Won,Ahn Sang Hoon,Yang Jin Mo,Jang Jae Young,Kweon Yong Oh,Cho Yong Kyun,Kim Yoon Jun,Hong Gun Young,Kim Dong Joon,Jung Young Kul,Um Soon Ho,Sohn Joo Hyun,Lee Jin Woo,Park Sung Jae,Lee Byung Seok,Kim Ju Hyun,Kim Hong Soo,Yoon Seung Kew,Kim Moon Young,Lee Kwan Sik,Lim Young Suk,Lee Wan Sik,Han Kwang-Hyub

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

3. Epidemiology of hepatitis B virus infection and impact of vaccination on disease;Nelson;Clin Liver Dis,2016

4. Current status and strategies for hepatitis B control in Korea;Cho;Clin Mol Hepatol,2017

5. Current status of liver diseases in Korea: Hepatitis B;Chae;Korean J Hepatol,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B;Gut and Liver;2024-01-12

2. Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy;Alimentary Pharmacology & Therapeutics;2023-04-28

3. Reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B receiving long-term besifovir therapy;2023-01-10

5. Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir;Biomedicines;2022-07-07